Business ❯ Pharmaceutical Industry ❯ Vaccine Development

Regulatory Affairs

AstraZeneca FDA Regulations Market Dynamics Product Liability FDA Approval Process

Pfizer and BioNTech Halt U.S. COVID Vaccine Trial for 50–64-Year-Olds Over Slow Enrollment

Tougher FDA rules are squeezing efforts to test shots in healthy adults 50 to 64.

Valneva Pulls U.S. Filings for Chikungunya Vaccine as FDA Halts Trials Over Safety Review